Our Recommendations
- Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19 (2021)
- Orientations sur l’élaboration d’un plan national de déploiement et de vaccination applicable aux vaccins contre la COVID-19 (2020)
- Immunization in the context of COVID-19 pandemic (2020)
- Institute for Health Metrics and Evaluation (2022)
- La vaccination dans le contexte de la pandémie de COVID-19 (2020)
New Publications
- Guidance on development and implementation of a national deployment and vaccination plan for vaccines against pandemic influenza and other respiratory viruses of pandemic potential (2023)
- The Big Catch-Up: An Essential Immunization Recovery Plan for 2023 and Beyond (2023)
- Modelling COVID-19 vaccination status and adherence to public health and social measures, Eastern Mediterranean Region and Algeria (2023)
- Meeting of the Strategic Advisory Group of Experts on Immunization, October 2022: conclusions and recommendations (2023)
- COVAX: Structure and Principles (2022)
Filter
482
Featured
Recommendations
71
Language
Document type
Fact sheets
129
Videos
87
Guidelines
60
Resource Platforms
57
Studies & Reports
47
Manuals
36
Infographics
21
Strategic & Response Plan
13
Training Material
9
Online Courses
8
Situation Updates
7
No document type
6
Brochures
1
App
1
Countries / Regions
Germany
38
Middle East and North Africa
20
Latin America and the Carribbean
18
Brazil
13
Ukraine
11
Russia
11
Africa
10
Syria
9
Yemen
9
West and Central Africa
8
East and Southern Africa
8
South Africa
6
South Sudan
5
China
4
Mozambique
4
Global
4
Congo, Democratic Republic of
4
United Kingdom
4
Sudan
4
Angola
4
Colombia
3
Guinea-Bissau
3
Lebanon
3
India
3
Philippines
2
Eastern Europe and Central Asia
2
Western and Central Europe
2
Argentina
2
Mali
2
Thailand
1
Kenya
1
Ghana
1
Sierra Leone
1
Kazakhstan
1
Nigeria
1
Canada
1
Senegal
1
Niger
1
Burkina Faso
1
Malawi
1
Morocco
1
USA
1
Saudi Arabia
1
South–East Asia Region
1
Gabon
1
Jamaica
1
Tunisia
1
South Korea
1
Belarus
1
French Guyana
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Bangladesh
1
Vietnam
1
Uganda
1
Nicaragua
1
Ethiopia
1
Indonesia
1
Somalia
1
Ecuador
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
126
Women & Child Health
19
Clinical Guidelines
9
Key Resources
8
Capacity Building
7
Pharmacy & Technologies
2
Public Health
1
Impfung gegen COVID-19 Erklärung für die Formulare mit Vektor-Impfstoff in Leichter Sprache
recommended
INFO Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019)–mit Vektor-Impfstoff –
21 Dec 2021. Slideset updated regularly to include the latest data and guidance on COVID-19 vaccines, including implications of emerging SARS-CoV-2 variants
Why does WHO recommend at this time, in June 2021, that vaccinating children is not a priority? When would their vaccination be prioritized? How is safety of these vaccines ensured? WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science in 5.
Les vaccins expliqués
recommended
La série « Les vaccins expliqués » de l’OMS présente des articles illustrés sur la mise au point et la distribution des vaccins, pour en savoir plus sur ces derniers, depuis les toutes premières étapes de la recherche jusqu’à leur déploiement dans les pays.
Mythes & COVID-19 Vaccins
recommended
MEDBOX Dossier no. 16. 28 Sept 2021.
De nombreuses études ont montré l'efficacité de la vaccination contre le COVID-19 et le fait qu'elle protège contre les maladies graves.
maladie grave. Un taux de vaccination élevé est nécessaire pour combattre la pandémie dans le monde entier. En raiso...
For most people in displacement contexts, there are simply not enough vaccines available in the places where they are hosted: 85% of refugees are hosted in lower- and middle-income countries, while in the first six months of this year 85% of vaccines went to wealthy countries; lower- and middle inco...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Rumors emerge when people feel left out of the discussion, when their questions cannot be answered by authorities or their doubts are dismissed by official sources. But also, rumors present an opportunity – to understand the questions, concerns and anxieties communities may have about this pandemi...
If you have had COVID-19, should you still get vaccinated ? Why are we not vaccinating children under 16? WHO’s Chief Scientist Dr Soumya Swaminathan explains these and other vaccine related questions in Science in 5 this week.
A imunização deve ser entendida como um regulador no processo saúde-doençae é uma das formas mais seguras e eficazesde prevenir enfermidades edereduzir a propagação de doenças existentes. Apesar disso, omovimento antivacinação alcançou uma ascendênciamundial,fator que pode provocar conse...
The Country Readiness and Delivery(CRD) workstream which is part of the ACT Accelerator and is included in the SPRP– has developed a toolbox with guidance, tools and training.
Das Gerücht hat beeindruckend viele verunsichert. Spoiler: Bitte weiterhin verhüten, danke. Produziert im Rahmen der #EUMythBusters.
This area contains an extensive repository of immunization resources submitted by our members.
Mobile vaccination teams visiting long-term care homes will have an important role in providing vaccination coverage for some of the most vulnerable population sub-groups. However, based on the experiences of German mobile diagnostic teams during the first COVID-19 pandemic w...
The overall goal of this strategy is to ensure accurate understanding of the
benefits of covid-19 vaccination and alleviate apprehension about the vaccine, to ensure its acceptance and encourage uptake across various audiences.
Objectives
x Create demand, promote acceptability and accessibility o...
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at...
Entwicklungen und gegenwärtige Situationen der Covid-19-Impfstoffe
26 July 2021
